AICDA and neoplasm: The design goal for DDiMAP is to evaluate tumor heterogeneity in follicular lymphoma, a cancer of B-lymphocytes that is well characterized with regard to ongoing AID-mediated somatic hypermutation of IGH, with the long-term objective of classifying FL based on their mutational patterns.